Developing and Paying for Gene Therapies—Can We Resolve the Conflicts?
Abstract
In this article, the opportunities and challenges associated with gene therapy are explored from the innovator, the payer, and the European perspectives.
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now